No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, ...

Alembic Pharmaceuticals has secured final USFDA approval for its generic version of Doxorubicin Hydrochloride Liposome, a ...

Now, Marc Franke says stem cell donor Anja Prause is "like a sister to me." Franke, 55, is one of very few people worldwide ...

Higher rates of cancers associated with immunosuppression in ethnically minoritized men living with HIV highlight gaps in HIV diagnosis and treatment.

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Cancer in Uganda is arguably one of the scariest diseases to think about, later alone suffer from or deal with a patient ...

It's incredibly scary to experience a random symptom out of nowhere, especially when it won't go away. So when I saw Reddit ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.

HSHS St. John's Hospital is pioneering a new procedure using blue light technology to enhance the detection of bladder cancer ...